Leadership & Pay ·
ZyVersa Therapeutics, Inc. announced the immediate resignation of independent director Min Chul Park, Ph.D., and is…
ZVSAZyVersa Therapeutics, Inc.
ZyVersa Therapeutics, Inc. announced the immediate resignation of independent director Min Chul Park, Ph.D., and is exploring cost-cutting measures to preserve cash, including potential product candidate divestitures, headcount reductions, and the possibility of suspending its SEC reporting obligations. CEO Stephen Glover and CFO Peter Wolfe have voluntarily accepted reduced compensation to support the company. ZyVersa Therapeutics, Inc. is a biotechnology company focused on developing therapeutic products.